Interleukin (IL)-6 is reported to function as a growth factor for renal and prostatic carcinomas. We conducted the present study to define the role of IL-6 in the growth of normal and neoplastic urothelial cells. Human bladder carcinoma cell lines (253J, RT4 and T24) and primary cultured human uroth
Secretion of functional hematopoietic growth factors by human carcinoma cell lines
β Scribed by Klaus G. Steube; Corinna Meyer; Hans G. Drexler
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- French
- Weight
- 71 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
We studied the constitutive production of hematopoietic cytokines in a large panel of human cell lines originating from a wide variety of solid tumors. Conditioned media (CM) from the carcinoma cell lines were collected and screened for proliferative activity using a bioassay with indicator cell lines. These indicator cell lines are dependent on hematopoietic growth factors and require the exogenous supply of at least one hematopoietic cytokine for proliferation. We found that CM of 27/70 cell lines were able to significantly and reproducibly stimulate [ 3 H]-thymidine incorporation of the factordependent cell lines, indicating that the tumor cell lines secreted one or more functional cytokine(s). The CMinduced proliferation of the indicator cell lines was significantly inhibited by anti-serum against granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte-CSF (G-CSF). ELISA confirmed the presence of one or several of the following cytokines in the CM of carcinoma cell lines: GM-CSF, G-CSF, macrophage-CSF (M-CSF), stem cell factor (SCF) and IL-6. A strikingly high percentage of GM-, Gor M-CSF-secreting cell lines was found among those lines derived from carcinomas of the kidney (100%), urinary bladder (85%) and pancreas (100%). The large majority of tumor cell lines derived from breast, colon, esophagus, lung, nervous system and melanomas did not produce significant amounts of the cytokines we investigated here. The cytokines secreted have been proven to be functionally active and can support growth and viability of cytokine-dependent hematopoietic cell lines.
π SIMILAR VOLUMES
## Background: Antiangiogenic therapy for prostatic cancer should offer additional ways of combating tumor progression. knowledge of the possible angiogenic factors expressed by prostate cancer cell lines would therefore assist in the design and testing of such potential treatments. ## Methods: C
The growth-stimulatory and invasion-promoting effects of basic fibroblast growth factor (bFGF) were examined in 2 series of related human colon carcinoma cell lines (HCT116A, HCT116B and 20-10-1 as well as and LS180, LS174T and ARK1A) that exhibit different invasive potentials. The invasive cell lin
## BACKGROUND. The predeliction for prostate carcinoma cells to metastasize to bone suggests the hypothesis that bone and/or bone marrow-derived factors may promote prostate carcinoma cell growth or survival, or serve as chemoattractants for these cells. METHODS. We screened three prostate carcino